TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
PEPTONIC medical AB
Closing information (x1000 EUR)
Closing information | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Turnover |
3,345
|
3,921
|
3,094 |
Financial expenses |
209
|
500
|
7 |
Earnings before taxes |
-3,838
|
-3,312
|
-7,205 |
EBITDA |
-3,147
|
-2,706
|
-4,563 |
Total assets |
9,619
|
7,706
|
8,165 |
Current assets |
3,642
|
2,818
|
2,649 |
Current liabilities |
2,831
|
3,151
|
3,078 |
Equity capital |
6,788
|
4,232
|
5,086 |
- share capital |
3,458
|
2,181
|
1,874 |
Employees (average) |
37
|
33
|
34 |
Financial ratios
Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Solvency |
70.6%
|
54.9%
|
62.3% |
Turnover per employee |
90
|
119
|
91 |
Profit as a percentage of turnover |
-114.7%
|
-84.5%
|
-232.9% |
Return on assets (ROA) |
-37.7%
|
-36.5%
|
-88.2% |
Current ratio |
128.6%
|
89.4%
|
86.1% |
Return on equity (ROE) |
-56.5%
|
-78.3%
|
-141.7% |
Change turnover |
-587
|
1,078
|
1,013 |
Change turnover % |
-15%
|
38%
|
49% |
Chg. No. of employees |
4
|
-1
|
15 |
Chg. No. of employees % |
12%
|
-3%
|
79% |
Total value of public sale
Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.